Tulsi (Basil)

Ocimum sanctum
Tulsi (Holy Basil) is a revered Ayurvedic herb, widely prevalent across the Indian subcontinent. Traditionally, it's claimed to balance Vata, Pitta, and Kapha doshas. This aromatic plant is highly valued for its supposed adaptogenic properties, often used for claimed benefits in managing stress, supporting respiratory health, and boosting immunity.
PLANT FAMILY
Lamiaceae (Mint)
PARTS USED
Leaves, Stem, Root
AYURVEDIC ACTION
Vata ↓, Pitta ↓, Kapha ↓
ACTIVE COMPOUNDS
Eugenol (70-80%)

What is Tulsi (Basil)?

Tulsi, or Holy Basil (scientific name: Ocimum sanctum), is an aromatic perennial plant in the mint family, Lamiaceae. Native to the Indian subcontinent, it is widely cultivated throughout the Southeast Asian tropics and is characterized by its fragrant leaves and small, often purplish flowers. This revered herb thrives in warm climates, growing as a small shrub up to a meter tall, and is recognized for its unique, pungent aroma.

Beyond its botanical characteristics, Tulsi holds significant cultural and traditional importance, particularly in Hindu spiritual practices, where it is often grown in courtyards and temples. It is distinguished from culinary basil varieties by its distinct flavor and traditional uses.

Other Names of Tulsi (Basil)

  • Holy Basil
  • Sacred Basil
  • The Incomparable One
  • Elixir of Life
  • Queen of Herbs
  • Rama Tulsi
  • Krishna Tulsi
  • Vana Tulsi

Benefits of Tulsi (Basil)

Heading

<h3> Absolute Contraindications of Tulsi (Holy Basil) </h3> <h4>Pregnancy - (avoid during pregnancy) [In layman terms]</h4> <ul> <li>🤰</li> <li>Recommendation: Do not use Tulsi extracts or concentrated products if you are pregnant or trying to conceive; avoid high-dose supplements and essential oils during pregnancy.</li> <li>Reasoning: Regulatory and safety reviews and some animal data raise concerns or identify data gaps about reproductive/developmental effects; authorities advise caution because safety in pregnancy is not established. </li> <li>Scientific_Study_Title: The Safety and Efficacy of Botanicals with Nootropic Effects (section addressing Ocimum tenuiflorum safety and reproductive concerns)</li> <li>Scientific_Study_Authors: (multiple) - review article on botanicals and safety (see source).</li> <li>Scientific_Study_Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762178/</li> <li>Scientific_Study_Excerpt: <p>Summary: A clinical and non-clinical safety review notes that EFSA and Health Canada have highlighted reproductive-toxicity data gaps for Ocimum tenuiflorum and advise against use during pregnancy and lactation. Although general toxicology at common doses appears acceptable, reproductive and developmental endpoints lack sufficient, high-quality data; therefore regulatory guidance recommends contraindication in pregnancy until clarified by targeted studies.</p> </li> </ul> <h4>Concurrent use with anticoagulant or bleeding disorders [In layman terms]</h4> <ul> <li>🩸</li> <li>Recommendation: If you are on blood thinners (e.g., warfarin) or have bleeding disorders, avoid Tulsi supplements and ask your clinician before using Tulsi tea or extracts; stop the herb before surgery per your doctor’s guidance.</li> <li>Reasoning: Animal and in-vitro studies show Tulsi extracts and oils can prolong bleeding time and inhibit platelet aggregation-this could increase bleeding risk when combined with anticoagulant or antiplatelet drugs.</li> <li>Scientific_Study_Title: Aqueous extracts of Ocimum basilicum L. decrease platelet aggregation induced by ADP and thrombin in vitro and rats arterio-venous shunt thrombosis in vivo</li> <li>Scientific_Study_Authors: S. M. Hajhashemi, et al. (see PubMed record)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/16469363/</li> <li>Scientific_Study_Excerpt: <p>Summary: In rodent models and in vitro assays, Ocimum basilicum aqueous extracts produced a dose-dependent inhibition of platelet aggregation (ADP and thrombin stimuli) and reduced thrombus weight comparable to aspirin at certain doses. Effects developed over several days and waned after stopping the extract, indicating a reversible but physiologically meaningful anti-platelet effect that could augment bleeding risk when combined with anticoagulant therapies.</p> </li> </ul> <h4>Concurrent use with antidiabetic medications / risk of hypoglycaemia [In layman terms]</h4> <ul> <li>🔻</li> <li>Recommendation: If you take insulin, sulfonylureas, or other glucose-lowering drugs, consult your prescribing clinician before using Tulsi regularly-your medication dose may need adjustment and blood glucose should be monitored.</li> <li>Reasoning: Human and animal trials document Tulsi’s glucose-lowering effects; combining Tulsi with glucose-lowering drugs can increase the chance of low blood sugar (hypoglycemia).</li> <li>Scientific_Study_Title: Randomized placebo-controlled, single blind trial of holy basil leaves in patients with noninsulin-dependent diabetes mellitus</li> <li>Scientific_Study_Authors: P Agrawal, V Rai, R B Singh</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/8880292/</li> <li>Scientific_Study_Excerpt: <p>Summary: In a randomized crossover trial, treatment with holy basil leaves produced statistically significant reductions in fasting and postprandial blood glucose compared with placebo (fasting blood glucose fell ~21 mg/dL). Authors conclude basil leaves may be useful adjuncts in mild-moderate type 2 diabetes-but the finding also implies potential for additive glucose lowering when used with standard antidiabetic drugs, warranting monitoring to avoid hypoglycemia.</p> </li> </ul> <h4>Concomitant use with sedative/barbiturate medications or prior to anesthesia/surgery [In layman terms]</h4> <ul> <li>😴</li> <li>Recommendation: Avoid Tulsi extracts and essential oils close to the time of anesthesia or if you are taking strong sedatives (e.g., barbiturates); tell your anesthesiologist about any herbal use.</li> <li>Reasoning: Animal studies show Tulsi oil can potentiate sedative agents (increasing sleeping time) and may inhibit hepatic enzymes that metabolize some sedatives, increasing their effects.</li> <li>Scientific_Study_Title: Effect of Ocimum sanctum fixed oil on blood pressure, blood clotting time and pentobarbitone-induced sleeping time</li> <li>Scientific_Study_Authors: R. K. Vijayaraghavan et al. (PubMed record)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/11694358/</li> <li>Scientific_Study_Excerpt: <p>Summary: In animal experiments, fixed oil from Ocimum sanctum prolonged pentobarbitone-induced sleeping time (a marker of sedative potentiation) and increased blood-clotting time. The findings suggest Tulsi oil components may inhibit hepatic drug-metabolizing enzymes and enhance sedative effects-important considerations for people taking central nervous system depressants or undergoing procedures requiring anesthesia.</p> </li> </ul> <h3> Relative Contraindications of Tulsi (Holy Basil) </h3> <h4>Drugs metabolized by CYP3A4 / CYP2B6 (e.g., rifampicin substrate examples, many common drugs)</h4> <ul> <li>⚖️</li> <li>Recommendation: If you take medications that are highly dependent on CYP3A4 or CYP2B6 (certain antivirals, immunosuppressants, some statins, antiretrovirals, etc.), discuss Tulsi use with your clinician and consider close monitoring or avoiding concentrated extracts.</li> <li>Reasoning: In vitro human liver microsome and cell studies indicate Tulsi extracts can inhibit or produce time-dependent inhibition of CYP2B6 and CYP3A4 and slow metabolism of model drugs (example: reduced conversion of rifampicin in assays), so co-administration could change drug levels.</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/32425779/</li> <li>Scientific_Study_Title: In Vitro Assessment of the Interaction Potential of Ocimum basilicum (L.) Extracts on CYP2B6, 3A4, and Rifampicin Metabolism</li> <li>Scientfic_Study_Authors: A. K. Lategan, et al.</li> <li>Scientific_Study_Excerpt: <p>Summary: Using human liver microsomes and HepG2 assays, aqueous and methanolic extracts of O. basilicum showed reversible and time-dependent inhibition of CYP2B6 and reduced formation of rifampicin metabolite in vitro. These results indicate a potential for Tulsi extracts to alter the metabolism of drugs that rely on these enzymes-an effect that merits caution and monitoring in clinical settings.</p> </li> </ul> <h4>Men trying to conceive / fertility concerns (high-dose or certain extracts) </h4> <ul> <li>👨‍👦</li> <li>Recommendation: Men actively trying to father a child should avoid high-dose concentrated Tulsi extracts until more human safety data are available; moderate culinary or occasional tea amounts are lower risk but discuss with a clinician if using supplements.</li> <li>Reasoning: Multiple animal studies report reversible reductions in sperm count, motility and changes in seminal parameters after prolonged or high-dose exposure-suggesting potential anti-fertility effects at certain doses or extracts.</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/12099405/</li> <li>Scientific_Study_Title: Reversible anti-fertility effect of benzene extract of Ocimum sanctum leaves on sperm parameters and fructose content in rats</li> <li>Scientfic_Study_Authors: S. K. Khanna, et al.</li> <li>Scientific_Study_Excerpt: <p>Summary: In a rat study, a benzene extract of O. sanctum administered for 48 days reduced total sperm count, motility and forward velocity while increasing abnormal sperm. The effects reversed after stopping treatment, indicating a dose-dependent and reversible anti-fertility action in this animal model that suggests caution for men using concentrated extracts while trying to conceive.</p> </li> </ul>

Heading

<h4>Low blood sugar / Hypoglycemia</h4> <ul> <li>🔻</li> <li>Side effect summary: Tulsi can lower blood sugar; if combined with diabetes drugs this may cause dangerously low glucose.</li> <li>Recommendation: Monitor blood glucose closely and consult your healthcare provider if you plan to add Tulsi to your regimen; medication doses may need adjustment.</li> <li>Reasoning: Human and animal trials show measurable reductions in fasting and postprandial glucose after Tulsi intake, implying additive effects with antidiabetic meds.</li> <li>Severity Level: Moderate</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Title: Randomized placebo-controlled, single blind trial of holy basil leaves in patients with noninsulin-dependent diabetes mellitus</li> <li>Scientific_Study_Authors: P Agrawal, V Rai, R B Singh</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/8880292/</li> <li>Scientific_Study_Excerpt: <p>Summary: In a crossover trial, holy basil leaf treatment significantly reduced fasting and postprandial blood glucose compared with placebo (fasting fell ~21 mg/dL). The trial supports a real glucose-lowering effect in humans and signals the need for monitoring when Tulsi is combined with pharmacologic glucose-lowering agents.</p> </li> </ul> <h4>Increased bleeding or easier bruising</h4> <ul> <li>🩹</li> <li>Side effect summary: Tulsi extracts, especially oils or concentrated preparations, can inhibit platelet aggregation and prolong bleeding time in animal models-this may translate into more bruising or bleeding risk in humans when combined with blood thinners.</li> <li>Recommendation: Avoid high-dose Tulsi preparations if you have bleeding disorders or take anticoagulants/antiplatelets; check with your clinician before starting.</li> <li>Reasoning: Dose-dependent platelet inhibition and reduced thrombus formation have been documented in vivo, providing a plausible mechanism for bleeding risk.</li> <li>Severity Level: Moderate</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Title: Aqueous extracts of Ocimum basilicum L. decrease platelet aggregation induced by ADP and thrombin in vitro and rats arterio-venous shunt thrombosis in vivo</li> <li>Scientific_Study_Authors: S. M. Hajhashemi, et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/16469363/</li> <li>Scientific_Study_Excerpt: <p>Summary: The study reports dose-dependent inhibition of ADP- and thrombin-induced platelet aggregation and significant reductions in thrombus weight in treated rats, with effects comparable to aspirin at certain doses-supporting a real potential for increased bleeding when combined with anticoagulant therapy.</p> </li> </ul> <h4>Mild gastrointestinal upset / nausea</h4> <ul> <li>🤢</li> <li>Side effect summary: Some users report mild nausea, diarrhea or stomach upset after taking Tulsi extracts or concentrated supplements.</li> <li>Recommendation: If you experience stomach upset, reduce the dose or stop use and consult a clinician; take with food if advised.</li> <li>Reasoning: Clinical safety reviews and trial reports list occasional mild GI complaints as the most common adverse events.</li> <li>Severity Level: Mild</li> <li>Scientific_Study_Available: Yes (safety review)</li> <li>Scientific_Study_Title: The Safety and Efficacy of Botanicals with Nootropic Effects (review including Ocimum tenuiflorum safety)</li> <li>Scientific_Study_Authors: (review authors; see PMC article)</li> <li>Scientific_Study_Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762178/</li> <li>Scientific_Study_Excerpt: <p>Summary: Clinical trial and safety reviews note rare and mostly mild adverse events with holy basil extracts in human studies, with nausea among the most commonly reported symptoms; overall tolerability is good at common doses but concentrated extracts can increase adverse event frequency.</p> </li> </ul>

Heading

<h4>Anticoagulants / Antiplatelet drugs (e.g., warfarin, aspirin, clopidogrel)</h4> <ul> <li>Interaction_Details: Tulsi extracts and oils inhibit platelet aggregation in animal and in-vitro models and can prolong bleeding time; combined use with anticoagulants or antiplatelet drugs may increase bleeding risk.</li> <li>Severity: Moderate</li> <li>Recommendation: Avoid combining concentrated Tulsi supplements or oils with anticoagulants without medical supervision; if combined, monitor bleeding parameters (INR for warfarin) and watch for signs of bleeding.</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/16469363/</li> <li>Scientific_Study_Title: Aqueous extracts of Ocimum basilicum L. decrease platelet aggregation induced by ADP and thrombin in vitro and rats arterio-venous shunt thrombosis in vivo</li> <li>Scientfic_Study_Authors: S. M. Hajhashemi, et al.</li> <li>Scientific_Study_Excerpt: <p>Summary: The study demonstrates dose-dependent inhibition of platelet aggregation by Ocimum basilicum extracts (ADP and thrombin pathways) and reduced thrombus weight in an AVT model, with effects that were comparable to aspirin at certain doses. The anti-platelet activity developed over days and reversed after stopping treatment, indicating potential for clinically meaningful interaction with anticoagulant or antiplatelet therapies.</p> </li> </ul> <h4>Antidiabetic agents (insulin, sulfonylureas, metformin adjuncts)</h4> <ul> <li>Interaction_Details: Tulsi lowers blood glucose in humans and animals; when taken with glucose-lowering drugs it can produce additive hypoglycemic effects.</li> <li>Severity: Moderate</li> <li>Recommendation: Monitor blood glucose closely and consult your prescribing clinician before starting Tulsi; medication dose adjustments may be necessary.</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/8880292/</li> <li>Scientific_Study_Title: Randomized placebo-controlled, single blind trial of holy basil leaves in patients with noninsulin-dependent diabetes mellitus</li> <li>Scientfic_Study_Authors: P Agrawal, V Rai, R B Singh</li> <li>Scientific_Study_Excerpt: <p>Summary: In a randomized crossover clinical trial, holy basil leaves significantly reduced fasting and postprandial blood glucose versus placebo-supporting a real glucose-lowering effect in people with type 2 diabetes and indicating risk of additive hypoglycemia when used with standard antidiabetic medications.</p> </li> </ul> <h4>CNS depressants / sedatives (e.g., barbiturates, benzodiazepines)</h4> <ul> <li>Interaction_Details: Animal data indicate Tulsi oil potentiates pentobarbitone-induced sleeping time and may inhibit hepatic enzymes that metabolize sedatives, increasing sedative effects.</li> <li>Severity: Mild</li> <li>Recommendation: Use caution combining Tulsi supplements or essential oils with strong sedatives; monitor for increased drowsiness and consult your clinician.</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/11694358/</li> <li>Scientific_Study_Title: Effect of Ocimum sanctum fixed oil on blood pressure, blood clotting time and pentobarbitone-induced sleeping time</li> <li>Scientfic_Study_Authors: R. K. Vijayaraghavan et al.</li> <li>Scientific_Study_Excerpt: <p>Summary: Fixed oil from Ocimum sanctum increased pentobarbitone-induced sleeping time in animal models-suggesting Tulsi components can potentiate sedative agents, likely via effects on hepatic metabolism and central nervous system depression; caution is warranted when combining with sedative drugs or before anesthesia.</p> </li> </ul> <h4>Drugs cleared primarily by CYP3A4 or CYP2B6 (e.g., some antiretrovirals, immunosuppressants, certain statins)</h4> <ul> <li>Interaction_Details: In vitro human liver microsome and cell line studies show Tulsi extracts can inhibit CYP2B6 and CYP3A4 and decrease metabolic conversion of model substrates (e.g., effects on rifampicin metabolism), which may alter plasma levels of co-administered drugs.</li> <li>Severity: Moderate</li> <li>Recommendation: Avoid starting concentrated Tulsi extracts without clinician review if you take narrow-therapeutic-index drugs metabolized by CYP3A4/2B6; consider monitoring drug levels or choosing to avoid the herb.</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/32425779/</li> <li>Scientific_Study_Title: In Vitro Assessment of the Interaction Potential of Ocimum basilicum (L.) Extracts on CYP2B6, 3A4, and Rifampicin Metabolism</li> <li>Scientfic_Study_Authors: Lategan AK, et al.</li> <li>Scientific_Study_Excerpt: <p>Summary: Methanolic and aqueous extracts of O. basilicum inhibited CYP2B6 activity (including time-dependent inhibition) in human liver microsomes and reduced formation of a rifampicin metabolite in vitro, indicating a plausible mechanism for clinically relevant herb-drug interactions with medicines metabolized by these enzymes.</p> </li> </ul>